Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Whitehawk Therapeutics, Inc. | 2,072,756 | reported | 14 May 2026 | tx 21+5,452,286−1,611,408 |
| ViewRay, Inc. | 740,080 | reported | 19 Jul 2023 | tx 30+2,655,762−2,345,030 |
| Neos Therapeutics, Inc. | 180,217 | reported | 28 Jul 2015 | tx 6+1,215,052−2,916,132 |
| Talaris Therapeutics, Inc. | 0 | reported | 28 Oct 2025 | tx 13+1,011,358−985,258 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 255,102 | 3.92 USD | |
| 14 May 2026 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 2,072,756 | 8124996.24 USD | deriv |
| 28 Oct 2025 | TENDER | Talaris Therapeutics, Inc. | 515,997 | — | |
| 28 Oct 2025 | TENDER | Talaris Therapeutics, Inc. | 431,939 | — | |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 10,000 | — | deriv |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 10,000 | — | deriv |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 16,800 | — | deriv |
| 15 Oct 2025 | GIFT | Talaris Therapeutics, Inc. | 522 | 0.00 USD | |
| 12 Jun 2025 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 40,006 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Talaris Therapeutics, Inc. | 16,800 | 0.00 USD | deriv |
| 04 Mar 2025 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 1,666,000 | 2.40 USD | |
| 12 Jun 2024 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 45,832 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Talaris Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 25 Oct 2023 | PURCHASE | Talaris Therapeutics, Inc. | 4,200 | 12.07 USD | first after silence |
| 27 Oct 2023 | PURCHASE | Talaris Therapeutics, Inc. | 15,800 | 14.55 USD | |
| 19 Oct 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 496,519 | — | |
| 19 Oct 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 458,039 | — | |
| 23 Oct 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 19 Jul 2023 | SALE | ViewRay, Inc. | 158,397 | 0.07 USD | |
| 19 Jul 2023 | SALE | ViewRay, Inc. | 1,545,600 | 0.07 USD | |
| 19 Jul 2023 | SALE | ViewRay, Inc. | 641,033 | 0.07 USD | |
| 15 Jun 2023 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 28,255 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | ViewRay, Inc. | 16,590 | 4.40 USD | |
| 26 Sept 2022 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 240,000 | 12.50 USD | |
| 15 Jun 2022 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 18,573 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 25 Oct 2023.